Exhibit 32.1
Certification
Pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
with Respect to the Annual Report on Form 10-K
for the Year Ended December 31, 2022
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), Nicole Sandford, President and Chief Executive Officer of Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Marlene McLennan, Interim Chief Financial Officer of the Company, each hereby certifies, to the best of her knowledge, that:
1. | The Company’s annual report on Form 10-K for the year ended December 31, 2022, to which this Certification is attached as Exhibit 32.1 (the “Form 10-K”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
2. | The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Bruce A. Huebner
|
Date: March 30, 2023 |
/s/ Nicole Sandford |
| Nicole Sandford President and Chief Executive Officer (Principal Executive Officer) |
Date: March 30, 2023 |
/s/ Marlene McLennan |
| Marlene McLennan Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
The certification set forth above is being furnished as an Exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Form 10-K or as a separate disclosure document of the Company or the certifying officers.